J&J proposes .5 billion settlement for lawsuits alleging talc causes cancer
Johnson & Johnson (J&J), the esteemed pharmaceutical and consumer goods company, has announced a landmark settlement agreement totaling .5 billion to resolve an extensive number of lawsuits in the United States. These lawsuits, estimated to be around 69,000, claim that the company’s now-discontinued talc-based baby powder was a significant factor in causing ovarian cancer among its users. This settlement represents approximately 99.75 percent of the outstanding talc-related legal cases across US federal and state courts.
The settlement, which was disclosed on Monday, is contingent upon acceptance by at least 95 percent of the claimants involved in the litigation. This development adds another chapter to J&J’s ongoing legal challenges related to its talc products, which had previously been a staple in cosmetics and baby care for decades. However, as scientific scrutiny intensified, concerns emerged regarding the mineral’s potential carcinogenic properties, leading to a significant decline in its use.
The World Health Organization (WHO) raised alarms in 2024 by classifying talc as “probably carcinogenic to humans.” Despite J&J’s claims of a lack of evidence linking talc to cancer, the company decided to cease sales of talc-based baby powder in the United States in 2020, followed by a global cessation in 2023. The roots of this litigation can be traced back to a pivotal 2016 case in which a jury ordered J&J to pay million to the family of a woman who died from ovarian cancer, citing the use of talc as a contributing factor. Although that judgment was later overturned, it set a precedent that encouraged a multitude of similar claims.
Erik Haas, the head of litigation at J&J, emphasized that this settlement will allow the company to “put this matter behind it,” indicating a desire to resolve the protracted legal disputes. Lawyers representing the plaintiffs regarded the agreement as a favorable conclusion to a decade-long legal battle. However, it is important to note that this settlement does not extend to the United Kingdom, where a significant product liability case is underway, potentially involving over 7,000 claimants. This UK case, filed in October 2025, alleges that J&J was aware of the cancer risks associated with its talc products but continued to market them—allegations the company also disputes. The case is currently under consideration by the UK High Court.
As the legal landscape surrounding talc products continues to evolve, J&J’s recent settlement signifies a pivotal moment in the intersection of corporate practices, public health concerns, and legal accountability.
#business #politics #entertainment #technology #environment
